Noncoding RNAs in cardiovascular diseases

Curr Opin Cardiol. 2019 May;34(3):241-245. doi: 10.1097/HCO.0000000000000615.

Abstract

Purpose of review: Human genome is pervasively transcribed, producing coding and noncoding RNAs. Recent studies have revealed the roles of a class of noncoding RNAs, the long noncoding RNAs (lncRNAs), in heart failure and other cardiovascular diseases. This review provides a brief summary of recent findings on lncRNA function.

Recent findings: Recent studies have documented the roles of lncRNAs in cardiac regeneration, conduction, hypertrophy/dysfunction, and endothelial function. LncRNAs perform these functions through acting as competing RNA (by binding and sequestering MicroRNAs) or acting as guides to protein targeting. A few lncRNAs also encode small peptides (e.g., Dwarf Open Reading Frame RNA) and in the context of heart regulate cardiac calcium homeostasis.

Summary: Noncoding RNA provides a versatile mechanism of gene regulation and thereby present as novel targets for intervention in various cardiovascular disease. Future studies aimed at defining the context-dependent lncRNA mechanisms will be required to advance our understanding and relish the goal of RNA therapeutics.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiovascular Diseases* / genetics
  • Gene Expression Regulation
  • Humans
  • MicroRNAs*
  • RNA, Long Noncoding*
  • RNA, Untranslated

Substances

  • MicroRNAs
  • RNA, Long Noncoding
  • RNA, Untranslated